Amarin Corporation plc. is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA® (icosapent ethyl), is available by prescription in certain countries, including in the United States. For more information about Amarin, visit www.amarincorp.com. For more information about VASCEPA, visit www.vascepahcp.com.
Brands: VASCEPA® (icosapent ethyl)